jid.2015.107

CORRIGENDA/ERRATUM

Genetic Heterogeneity of Pseudoxanthoma Elasticum: The Chinese Signature Profile of ABCC6 and ENPP1 Mutations

Liang Jin, Qiujie Jiang, Zhengsheng Wu, Changxia Shao, Yong Zhou, Luting Yang, Jouni Uitto and Gang Wang Journal of Investigative Dermatology (2015) 135, 2338; doi:10.1038/jid.2015.202; published online 18 June 2015

Correction to: Journal of Investigative Dermatology (2015) 135, 1294–1302; doi:10.1038/jid.2015.10; published online 19 February 2015 Following the publication of this article, the authors noted an error in Figure 1a. One of the nucleotide variants was described as 3586delG; the correct mutation should be 3586delC. This error does not alter the conclusions on the consequences of this mutation. The authors apologize for the error.

Expression of Protease-Activated Receptor-2 in SZ95 Sebocytes and its Role in Sebaceous Lipogenesis, Inflammation, and Innate Immunity

Sang E. Lee, Ji-Min Kim, Se K. Jeong, Eung H. Choi, Christos C. Zouboulis and Seung H. Lee Journal of Investigative Dermatology (2015) 135, 2338; doi:10.1038/jid.2015.219; published online 25 June 2015

Correction to: Journal of Investigative Dermatology advance online publication, 14 May 2015; doi:10.1038/jid.2015.151 Following the online publication of this article, the authors noted that the following section was missing: ACKNOWLEDGMENTS This work was supported by a faculty research grant of Yonsei University College of Medicine for 2012 (6–2012–0190). The authors regret the error.

Ruxolitinib Attenuates Cutaneous Lupus Development in a Mouse Lupus Model

Emilie S. Chan, Leal C. Herlitz and Ali Jabbari Journal of Investigative Dermatology (2015) 135, 2338–2339; doi:10.1038/jid.2015.216; published online 2 July 2015

Correction to: Journal of Investigative Dermatology advance online publication, 9 April 2015; doi:10.1038/jid.2015.107 Following the publication of this article, the authors noted an error in the middle panel of Figure 2a, which was incorrectly labeled as ‘Cxcl9’. The correct label is Cxcl10. The revised figure appears on the following page. The publisher regrets the error.

2338 Journal of Investigative Dermatology (2015), Volume 135

© 2015 The Society for Investigative Dermatology

Corrigenda/Erratum

Relative expression

Cxcl9 128 64 32 16 8 4 2 1 0.5 0.25 0.125 IFN:

Cxcl10

*

*** *** *** ***

–

α

γ

Ruxolitinib: –

–

–

CD4

Cxcl11

** ** **

**

–

α

–

–

α/γ

γ –

**

–

*

** *

–

α

γ

–

–

–

*

*

*

*

α/γ –

CD8

80

Number of cells per hpf

Ruxolitinib

128 64 32 16 8 4 2 1 0.5 0.25 0.125

*

Vehicle

CD3

α/γ –

128 64 32 16 8 4 2 1 0.5 0.25 0.125

Vehicle Vehicle, nonlesional Ruxolitinib

60

40

** 20

*** ***

*

0 Vehicle, nonlesional

*

***

CD3+

cells

CD4+

cells

CD8+

cells

www.jidonline.org 2339